Table 1 Baseline characteristics of participants

Age (years)

48.25 ± 12.86

Male, n (%)

111 (35.7)

Han, n (%)

309 (99.4)

BMI (kg/m²)

23.24 (20.90, 25.80)

WHR

0.88 ± 0.08

Smoking, n (%)

67 (21.5)

Drinking, n (%)

81 (26.0)

Diabetes, n (%)

21 (6.8)

Hypertension, n (%)

48 (15.4)

Dyslipidemia, n (%)

31 (10.0)

Antidiabetic treatment, n (%)

16 (5.1)

Antihypertensive treatment, n (%)

35 (11.3)

FPG (mmol/L)

4.82 (4.54, 5.18)

SBP (mmHg)

114.00 (102.67, 129.33)

DBP (mmHg)

75.97 ± 10.98

TC (mmol/L)

4.78 ± 0.91

TG (mmol/L)

1.03 (0.80, 1.52)

LDL-C (mmol/L)

2.78 (2.27, 3.31)

HDL-C (mmol/L)

1.60 ± 0.34

Non-HDL-C (mmol/L)

3.18 ± 0.90

TC/HDL-C

2.94 (2.54, 3.46)

LDL-C/HDL-C

1.79 (1.41, 2.23)

ALT (IU/L)

19.00 (15.00, 28.00)

AST (IU/L)

22.00 (19.00, 27.00)

BUN (mmol/L)

5.39 (4.34, 6.54)

Cr (umol/L)

55.44 ± 14.56

IMT (mm)

0.70 (0.60, 0.80)

Carotid plaques, n (%)

49 (15.8)